Abraxis Bioscience, Inc. (ABII.O)
ABII.O on Nasdaq
35.22USD
9 Feb 2010
35.22USD
9 Feb 2010
Price Change (% chg)
$-3.18 (-8.28%)
$-3.18 (-8.28%)
Prev Close
$35.22
$35.22
Open
--
--
Day's High
$38.63
$38.63
Day's Low
$34.80
$34.80
Volume
165,354
165,354
Avg. Vol
86,350
86,350
52-wk High
$73.98
$73.98
52-wk Low
$24.52
$24.52
About
Abraxis BioScience, Inc. (Abraxis) is an integrated biotechnology company. The Company is engaged in the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients treatments for cancer and other critical illnesses. The Company’s portfolio includes protein-based nanoparticle... (more)
Overall
| Beta: | 0.44 |
| Market Cap (Mil.): | $1,412.57 |
| Shares Outstanding (Mil.): | 40.11 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ABII.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 11.50 | 3.76 |
| EPS (TTM): | -165.24 | -- | -- |
| ROI: | -24.18 | 1.25 | 2.30 |
| ROE: | -27.09 | 2.09 | 2.82 |
Competitors
| Price | Change | |
|---|---|---|
| Bristol Myers Squibb Co. (BMY.N) | $24.25 | +0.29 |
| Bristol Myers Squibb Co. (BMY_p.N) | $439.50 | 0.00 |
| Sanofi-Aventis SA (SASY.PA) | €52.86 | +0.20 |





Earnings vs
Estimates